Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current.
paper
Cited
Public
Unavailable
- Authors
- Best, Tyler K; Siarey, Richard J; Galdzicki, Zygmunt
- Year
- 2007
- Journal
- Journal of neurophysiology
- PMID
- 17093127
- DOI
- 10.1152/jn.00626.2006
Down syndrome (DS) is the most common nonheritable cause of mental retardation. DS is the result of the presence of an extra chromosome 21 and its phenotype may be a consequence of overexpressed genes from that chromosome. One such gene is Kcnj6/Girk2, which encodes the G-protein-coupled inward rectifying potassium channel subunit 2 (GIRK2). We have recently shown that the DS mouse model, Ts65Dn, overexpresses GIRK2 throughout the brain and in particular the hippocampus. Here we report that this overexpression leads to a significant increase ( approximately 2-fold) in GABA(B)-mediated GIRK current in primary cultured hippocampal neurons. The dose response curves for peak and steady-state GIRK current density is significantly shifted left toward lower concentrations of baclofen in Ts65Dn neurons compared with diploid controls, consistent with increased functional expression of GIRK channels. Stationary fluctuation analysis of baclofen-induced GIRK current from Ts65Dn neurons indicated no significant change in single-channel conductance compared with diploid. However, significant increases in GIRK channel density was found in Ts65Dn neurons. In normalized baclofen-induced GIRK current and GIRK current kinetics no difference was found between diploid and Ts65Dn neurons, which suggests unimpaired mechanisms of interaction between GIRK channel and GABA(B) receptor. These results indicate that increased expression of GIRK2 containing channels have functional consequences that likely affect the balance between excitatory and inhibitory neuronal transmission.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A critical residue mediates proper assembly and gating of GIRK2 channels. | Nguyen H et al. | β | 2026 | β |
| sAPPΞ± Inhibits Neurite Outgrowth in Primary Mouse Neurons via GABA B Receptor Subunit 1a. | Barber D et al. | β | 2026 | β |
| Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility. | Shao LR et al. | β | 2025 | β |
| Understanding the neurobiology of infantile epileptic spasms syndrome (IESS): A comprehensive review. | Modgil A et al. | β | 2025 | β |
| Amyloid-Ξ² oligomers trigger sex-dependent inhibition of GIRK channel activity in hippocampal neurons in mice. | Luo H et al. | β | 2024 | β |
| Dysfunctions of cellular context-sensitivity in neurodevelopmental learning disabilities. | Granato A et al. | β | 2024 | β |
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | Popova D et al. | β | 2023 | β |
| Brain circuit pathology in Down syndrome: from neurons to neural networks. | Bartesaghi R | β | 2023 | β |
| Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome. | Thomazeau A et al. | β | 2023 | β |
| Animal Models in Epileptic Spasms and the Development of Novel Treatment Options. | Barrett KT et al. | β | 2022 | β |
| Enhanced GIRK2 channel signaling in Down syndrome: A feasible role in the development of abnormal nascent neural circuits. | Kleschevnikov AM | β | 2022 | β |
| GABA<sub>B</sub> Receptors and Cognitive Processing in Health and Disease. | Vlachou S | β | 2022 | β |
| GIRK2 Channels in Down Syndrome and Alzheimer's Disease. | Kleschevnikov A | β | 2022 | β |
| Meta-Analysis of Down Syndrome Cortical Development Reveals Underdeveloped State of the Science. | Risgaard KA et al. | β | 2022 | β |
| Neuronal G protein-gated K<sup>+</sup> channels. | Luo H et al. | β | 2022 | β |
| Rodent Modeling of Alzheimer's Disease in Down Syndrome: <i>In vivo</i> and <i>ex vivo</i> Approaches. | Farrell C et al. | β | 2022 | β |
| Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. | Brault V et al. | β | 2021 | β |
| <i>Dyrk1a</i>gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome | Brault V et al. | β | 2021 | β |
| Physical Exercise Modulates Brain Physiology Through a Network of Long- and Short-Range Cellular Interactions. | Consorti A et al. | β | 2021 | β |
| Signalling pathways contributing to learning and memory deficits in the Ts65Dn mouse model of Down syndrome. | Freeburn A et al. | β | 2021 | β |
| Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. | Jeremic D et al. | β | 2021 | β |
| Challenges and Opportunities for Translation ofΒ Therapies to Improve Cognition in DownΒ Syndrome. | Lee SE et al. | β | 2020 | β |
| Identification of a G-Protein-Independent Activator of GIRK Channels. | Zhao Y et al. | β | 2020 | β |
| Infantile Spasms: An Update on Pre-Clinical Models and EEG Mechanisms. | Janicot R et al. | β | 2020 | β |
| Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome. | Rueda N et al. | β | 2020 | β |
| Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels. | Kozek KA et al. | β | 2019 | β |
| Down syndrome. | Rafii MS et al. | β | 2019 | β |
| Down syndrome: Neurobiological alterations and therapeutic targets. | Vacca RA et al. | β | 2019 | β |
| Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice. | Raveau M et al. | β | 2018 | β |
| Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome. | Lysenko LV et al. | β | 2018 | β |
| GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome. | Zorrilla de San Martin J et al. | β | 2018 | β |
| Kcnj6(GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome. | Joshi K et al. | β | 2018 | β |
| Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome. | Kleschevnikov AM et al. | β | 2017 | β |
| G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channel Activation by the p75 Neurotrophin Receptor Is Required for Amyloid Ξ² Toxicity. | May LM et al. | β | 2017 | β |
| Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome. | RoncacΓ© V et al. | β | 2017 | β |
| The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome. | Contestabile A et al. | β | 2017 | β |
| Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome. | Goodliffe JW et al. | β | 2016 | β |
| Experience-dependent reduction of soluble Ξ²-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome. | Sansevero G et al. | β | 2016 | β |
| GABAB receptor-mediated, layer-specific synaptic plasticity reorganizes gamma-frequency neocortical response to stimulation. | Ainsworth M et al. | β | 2016 | β |
| GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App. | Mojabi FS et al. | β | 2016 | β |
| G Protein-Gated K<sup>+</sup> Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning. | Victoria NC et al. | β | 2016 | β |
| Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel. | Joshi K et al. | β | 2016 | β |
| Pediatric Epileptic Encephalopathies: Pathophysiology and Animal Models. | Shao LR et al. | β | 2016 | β |
| Reduced cortical neurotransmitter receptor complex levels in fetal Down syndrome brain. | Falsafi SK et al. | β | 2016 | β |
| Role of GABA(B) receptors in learning and memory and neurological disorders. | Heaney CF et al. | β | 2016 | β |
| Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome. | Cramer NP et al. | β | 2015 | β |
| Cerebal overinhibition could be the basis for the high prevalence of epilepsy in persons with Down syndrome. | Araujo BH et al. | β | 2015 | β |
| GIRK Channels: A Potential Link Between Learning and Addiction. | Tipps ME et al. | β | 2015 | β |
| Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice. | Stern S et al. | β | 2015 | β |
| Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies. | Galanopoulou AS et al. | β | 2015 | β |
| Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. | Gardiner KJ | β | 2015 | β |
| Prenatal protein malnutrition decreases KCNJ3 and 2DG activity in rat prefrontal cortex. | Amaral AC et al. | β | 2015 | β |
| The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists. | Blichowski M et al. | β | 2015 | β |
| Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome. | Begenisic T et al. | β | 2014 | β |
| New insights into the therapeutic potential of Girk channels. | LujΓ‘n R et al. | β | 2014 | β |
| Treating enhanced GABAergic inhibition in Down syndrome: use of GABA Ξ±5-selective inverse agonists. | MartΓnez-CuΓ© C et al. | β | 2014 | β |
| Autism spectrum disorders: the quest for genetic syndromes. | Zafeiriou DI et al. | β | 2013 | β |
| GABAergic dysfunction in pediatric neuro-developmental disorders. | Smith-Hicks CL | β | 2013 | β |
| Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. | Wang X et al. | β | 2013 | β |
| Prospects for improving brain function in individuals with Down syndrome. | Costa AC et al. | β | 2013 | β |
| Aberrant epigenetic landscape in intellectual disability. | Sanchez-Mut JV et al. | β | 2012 | β |
| Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome. | Ruparelia A et al. | β | 2012 | β |
| Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. | Kleschevnikov AM et al. | β | 2012 | β |
| Discoveries in Down syndrome: moving basic science to clinical care. | Kleschevnikov AM et al. | β | 2012 | β |
| Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome. | Best TK et al. | β | 2012 | β |
| Enriching the environment to disinhibit the brain and improve cognition. | Maffei A | β | 2012 | β |
| From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome. | Cramer N et al. | β | 2012 | β |
| GIRK channel modulation by assembly with allosterically regulated RGS proteins. | Zhou H et al. | β | 2012 | β |
| Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. | Kleschevnikov AM et al. | β | 2012 | β |
| Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome. | Vidal V et al. | β | 2012 | β |
| Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics. | CrΓ©au N | β | 2012 | β |
| Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. | Rueda N et al. | β | 2012 | β |
| Prenatal treatment prevents learning deficit in Down syndrome model. | Incerti M et al. | β | 2012 | β |
| Synaptic pathology of Down syndrome. | Garner CC et al. | β | 2012 | β |
| Chronic Treatment with a Promnesiant GABA-A Ξ±5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model. | Braudeau J et al. | β | 2011 | β |
| Down syndrome: searching for the genetic culprits. | Lana-Elola E et al. | β | 2011 | β |
| In vitro profiling of epigenetic modifications underlying heavy metal toxicity of tungsten-alloy and its components. | Verma R et al. | β | 2011 | β |
| Is it possible to improve neurodevelopmental abnormalities in Down syndrome? | Bartesaghi R et al. | β | 2011 | β |
| Specific targeting of the GABA-A receptor Ξ±5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice. | Braudeau J et al. | β | 2011 | β |
| Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21. | Ruparelia A et al. | β | 2010 | β |
| Emerging pharmacotherapies for neurodevelopmental disorders. | Wetmore DZ et al. | β | 2010 | β |
| GABAB-GIRK2-mediated signaling in Down syndrome. | Cramer NP et al. | β | 2010 | β |
| Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). | Roubertoux PL et al. | β | 2010 | β |
| Aneuploidy: from a physiological mechanism of variance to Down syndrome. | Dierssen M et al. | β | 2009 | β |
| A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. | Pereira PL et al. | β | 2009 | β |
| Down syndrome--recent progress and future prospects. | Wiseman FK et al. | β | 2009 | β |
| Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. | Slonim DK et al. | β | 2009 | β |
| Infantile spasms: a critical review of emerging animal models. | Stafstrom CE | β | 2009 | β |
| Infantile spasms and Down syndrome: a new animal model. | Cortez MA et al. | β | 2009 | β |
| Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and gamma-aminobutyric acid receptors. | Vink J et al. | β | 2009 | β |
| The impact of spermine synthase (SMS) mutations on brain morphology. | Kesler SR et al. | β | 2009 | β |
| Prevention of developmental delays in a Down syndrome mouse model. | Toso L et al. | β | 2008 | β |
| Speeding of miniature excitatory post-synaptic currents in Ts65Dn cultured hippocampal neurons. | Best TK et al. | β | 2008 | β |
| Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. | Rachidi M et al. | β | 2007 | β |